In disease prognostic models, ANGPTL4 has demonstrated diagnostic potential, with an AUC of 0.7665, and its expression in RCC tumor samples is significantly greater than that in normal kidney tissue (Li L. et al., 2023). This evidence concerns the gene ANGPTL4 and neoplasm.